The life sciences comprise fields of science involving the study of living organisms such as plants, animals and humans.
While biology remains the centerpiece of the life sciences, technological advances in molecular biology and biotechnology have led to a burgeoning of specializations and new interdisciplinary fields.
Because of the extremely high research and development costs coupled with little revenue in the initial years of development, many life sciences firms partner with larger firms to complete product development.
To a large extent, companies in the life sciences industry have already recognized that digital transformation – pushed forward by 5G technology and the like — will lead to changing roles in the ecosystem.
The possibilities include entirely new business models, in which patients receive a proactive healthcare service that is very different from today’s predominantly reactive treatment. There will also be mutually beneficial alliances and collaborations between incumbent and new stakeholders (e.g., tech companies) with no past experience in pharmaceuticals.
Without question, one of the most important factors driving this change will be the exchange of information between stakeholders — from patient data, R&D, and production through communication between suppliers, insurers, doctors, and other key influencers. The digitalization of these processes and the exchange of data will be key.
There’s sufficient evidence that technologies are already — or soon will be — contributing to finding treatments for diseases that are difficult to cure or that are currently incurable.
In the new life sciences ecosystem, the patient takes center stage. Many companies are slowly beginning to understand how digitalization is absolutely instrumental in this important step. The potential of combining the most promising healthcare-related technologies with data and analytics is a game-changer.
Today, virtually all complex diagnostic procedures are carried out during hospitalization. Soon, however, this could be a thing of the past, as several of these procedures could be carried out at home via ingestible sensors or other on-body devices.
In addition, wearable fitness trackers, which are already used by millions, could facilitate health monitoring in the future. Technology is now so far advanced that in the field of oncology, artificial intelligence is already being used to create an individual patient-specific treatment plan based on a combination of data from the patient as well as relevant studies.
This technology not only benefits the patient but also provides fundamental support for the physician.
Life Sciences Courses by Tonex
Life sciences training programs, seminars and workshops address the study of living organisms and life processes involving cells and their components, products and processes. Biology, Biotechnology, Genetics and Molecular Biology, Biochemistry, Medicine, Agricultural and Biological Sciences, Environmental Science, Immunology and Microbiology, Neuroscience, and other areas.
Tonex offers several innovative and trenchant courses that explore various aspects of life sciences and its melding with today’s advances in technology.
For more information, questions, comments, contact us.